JCR Pharmaceuticals Receives Orphan Drug Designation from the Ministry of Health, Labour and Welfare of Japan for Givinostat for Duchenne Muscular Dystrophy – Business Wire
4 weeks ago · Google News - Japan
Global Japan
& newspaper;
Read Full Article →
Sourced From
Google News - Japan
JCR Pharmaceuticals Receives Orphan Drug Designation from the Ministry of Health, Labour and Welfare of Japan for Givinostat for Duchenne Muscular Dystrophy Business Wire
Source: Google News – Japan — Read full article →
Content sourced from third parties. Copyright belongs to original publishers.
Source: Google News - Japan — Read full article at source →
Content sourced from third parties. Copyright belongs to original publishers. Only excerpt and link are stored under fair use.